nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C8—Sorafenib—thyroid cancer	0.121	0.167	CbGbCtD
Loratadine—CYP2C19—Sorafenib—thyroid cancer	0.102	0.14	CbGbCtD
Loratadine—CYP2C9—Sorafenib—thyroid cancer	0.0845	0.117	CbGbCtD
Loratadine—ABCB1—Sorafenib—thyroid cancer	0.082	0.113	CbGbCtD
Loratadine—CYP3A4—Vandetanib—thyroid cancer	0.0815	0.113	CbGbCtD
Loratadine—CYP2D6—Sorafenib—thyroid cancer	0.0773	0.107	CbGbCtD
Loratadine—ABCB1—Doxorubicin—thyroid cancer	0.0498	0.0687	CbGbCtD
Loratadine—CYP3A4—Sorafenib—thyroid cancer	0.0492	0.0679	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—thyroid cancer	0.0469	0.0648	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—thyroid cancer	0.0298	0.0412	CbGbCtD
Loratadine—Chromaturia—Vandetanib—thyroid cancer	0.0196	0.071	CcSEcCtD
Loratadine—Dermatitis bullous—Vandetanib—thyroid cancer	0.00532	0.0193	CcSEcCtD
Loratadine—Lethargy—Vandetanib—thyroid cancer	0.00519	0.0188	CcSEcCtD
Loratadine—Drug interaction—Sorafenib—thyroid cancer	0.00509	0.0184	CcSEcCtD
Loratadine—Gastritis—Vandetanib—thyroid cancer	0.0045	0.0163	CcSEcCtD
Loratadine—Pollakiuria—Vandetanib—thyroid cancer	0.00406	0.0147	CcSEcCtD
Loratadine—Depression—Vandetanib—thyroid cancer	0.00391	0.0142	CcSEcCtD
Loratadine—Hepatobiliary disease—Vandetanib—thyroid cancer	0.0037	0.0134	CcSEcCtD
Loratadine—Epistaxis—Vandetanib—thyroid cancer	0.00369	0.0134	CcSEcCtD
Loratadine—Arrhythmia—Vandetanib—thyroid cancer	0.00314	0.0114	CcSEcCtD
Loratadine—Abdominal pain upper—Sorafenib—thyroid cancer	0.00313	0.0113	CcSEcCtD
Loratadine—Alopecia—Vandetanib—thyroid cancer	0.00311	0.0113	CcSEcCtD
Loratadine—Gastritis—Sorafenib—thyroid cancer	0.00303	0.011	CcSEcCtD
Loratadine—Dysgeusia—Vandetanib—thyroid cancer	0.003	0.0109	CcSEcCtD
Loratadine—Loss of consciousness—Vandetanib—thyroid cancer	0.00269	0.00975	CcSEcCtD
Loratadine—Cough—Vandetanib—thyroid cancer	0.00267	0.00968	CcSEcCtD
Loratadine—Hypertension—Vandetanib—thyroid cancer	0.00264	0.00958	CcSEcCtD
Loratadine—Chest pain—Vandetanib—thyroid cancer	0.00261	0.00944	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00259	0.00938	CcSEcCtD
Loratadine—Dry mouth—Vandetanib—thyroid cancer	0.00255	0.00923	CcSEcCtD
Loratadine—Hepatobiliary disease—Sorafenib—thyroid cancer	0.0025	0.00905	CcSEcCtD
Loratadine—Epistaxis—Sorafenib—thyroid cancer	0.00249	0.00903	CcSEcCtD
Loratadine—Nervous system disorder—Vandetanib—thyroid cancer	0.00245	0.00888	CcSEcCtD
Loratadine—Skin disorder—Vandetanib—thyroid cancer	0.00243	0.00879	CcSEcCtD
Loratadine—Blister—Epirubicin—thyroid cancer	0.00242	0.00877	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00228	0.00825	CcSEcCtD
Loratadine—Insomnia—Vandetanib—thyroid cancer	0.00226	0.00819	CcSEcCtD
Loratadine—Paraesthesia—Vandetanib—thyroid cancer	0.00224	0.00813	CcSEcCtD
Loratadine—Blister—Doxorubicin—thyroid cancer	0.00224	0.00812	CcSEcCtD
Loratadine—Tinnitus—Sorafenib—thyroid cancer	0.00221	0.00801	CcSEcCtD
Loratadine—Dyspepsia—Vandetanib—thyroid cancer	0.0022	0.00797	CcSEcCtD
Loratadine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00216	0.00781	CcSEcCtD
Loratadine—Fatigue—Vandetanib—thyroid cancer	0.00215	0.0078	CcSEcCtD
Loratadine—Immune system disorder—Sorafenib—thyroid cancer	0.00214	0.00776	CcSEcCtD
Loratadine—Pain—Vandetanib—thyroid cancer	0.00214	0.00774	CcSEcCtD
Loratadine—Constipation—Vandetanib—thyroid cancer	0.00214	0.00774	CcSEcCtD
Loratadine—Arrhythmia—Sorafenib—thyroid cancer	0.00212	0.00768	CcSEcCtD
Loratadine—Alopecia—Sorafenib—thyroid cancer	0.0021	0.00759	CcSEcCtD
Loratadine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00204	0.0074	CcSEcCtD
Loratadine—Dysgeusia—Sorafenib—thyroid cancer	0.00202	0.00733	CcSEcCtD
Loratadine—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00199	0.0072	CcSEcCtD
Loratadine—Abdominal pain—Vandetanib—thyroid cancer	0.00197	0.00716	CcSEcCtD
Loratadine—Body temperature increased—Vandetanib—thyroid cancer	0.00197	0.00716	CcSEcCtD
Loratadine—Viral infection—Epirubicin—thyroid cancer	0.00193	0.007	CcSEcCtD
Loratadine—Angioedema—Sorafenib—thyroid cancer	0.00189	0.00684	CcSEcCtD
Loratadine—Syncope—Sorafenib—thyroid cancer	0.00185	0.00671	CcSEcCtD
Loratadine—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00184	0.00666	CcSEcCtD
Loratadine—Loss of consciousness—Sorafenib—thyroid cancer	0.00181	0.00658	CcSEcCtD
Loratadine—Cough—Sorafenib—thyroid cancer	0.0018	0.00653	CcSEcCtD
Loratadine—Asthenia—Vandetanib—thyroid cancer	0.00179	0.00649	CcSEcCtD
Loratadine—Viral infection—Doxorubicin—thyroid cancer	0.00179	0.00648	CcSEcCtD
Loratadine—Hypertension—Sorafenib—thyroid cancer	0.00178	0.00646	CcSEcCtD
Loratadine—Myalgia—Sorafenib—thyroid cancer	0.00176	0.00637	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00175	0.00633	CcSEcCtD
Loratadine—Dry mouth—Sorafenib—thyroid cancer	0.00172	0.00623	CcSEcCtD
Loratadine—Diarrhoea—Vandetanib—thyroid cancer	0.00171	0.00619	CcSEcCtD
Loratadine—Salivary hypersecretion—Epirubicin—thyroid cancer	0.0017	0.00614	CcSEcCtD
Loratadine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00169	0.00611	CcSEcCtD
Loratadine—Shock—Sorafenib—thyroid cancer	0.00166	0.00601	CcSEcCtD
Loratadine—Nervous system disorder—Sorafenib—thyroid cancer	0.00165	0.00599	CcSEcCtD
Loratadine—Dizziness—Vandetanib—thyroid cancer	0.00165	0.00599	CcSEcCtD
Loratadine—Skin disorder—Sorafenib—thyroid cancer	0.00164	0.00593	CcSEcCtD
Loratadine—Vomiting—Vandetanib—thyroid cancer	0.00159	0.00576	CcSEcCtD
Loratadine—Rash—Vandetanib—thyroid cancer	0.00158	0.00571	CcSEcCtD
Loratadine—Dermatitis—Vandetanib—thyroid cancer	0.00157	0.0057	CcSEcCtD
Loratadine—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00157	0.00568	CcSEcCtD
Loratadine—Headache—Vandetanib—thyroid cancer	0.00156	0.00567	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00154	0.00556	CcSEcCtD
Loratadine—Nausea—Vandetanib—thyroid cancer	0.00148	0.00538	CcSEcCtD
Loratadine—Dyspepsia—Sorafenib—thyroid cancer	0.00148	0.00537	CcSEcCtD
Loratadine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00145	0.00527	CcSEcCtD
Loratadine—Fatigue—Sorafenib—thyroid cancer	0.00145	0.00526	CcSEcCtD
Loratadine—Pain—Sorafenib—thyroid cancer	0.00144	0.00522	CcSEcCtD
Loratadine—Constipation—Sorafenib—thyroid cancer	0.00144	0.00522	CcSEcCtD
Loratadine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00138	0.00499	CcSEcCtD
Loratadine—Increased appetite—Epirubicin—thyroid cancer	0.00135	0.00489	CcSEcCtD
Loratadine—Abdominal pain—Sorafenib—thyroid cancer	0.00133	0.00483	CcSEcCtD
Loratadine—Body temperature increased—Sorafenib—thyroid cancer	0.00133	0.00483	CcSEcCtD
Loratadine—Dermatitis bullous—Epirubicin—thyroid cancer	0.00133	0.0048	CcSEcCtD
Loratadine—Lethargy—Epirubicin—thyroid cancer	0.00129	0.00469	CcSEcCtD
Loratadine—Increased appetite—Doxorubicin—thyroid cancer	0.00125	0.00452	CcSEcCtD
Loratadine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00123	0.00444	CcSEcCtD
Loratadine—Asthenia—Sorafenib—thyroid cancer	0.00121	0.00438	CcSEcCtD
Loratadine—Lethargy—Doxorubicin—thyroid cancer	0.0012	0.00434	CcSEcCtD
Loratadine—Abdominal pain upper—Epirubicin—thyroid cancer	0.00116	0.00419	CcSEcCtD
Loratadine—Diarrhoea—Sorafenib—thyroid cancer	0.00115	0.00418	CcSEcCtD
Loratadine—Gastritis—Epirubicin—thyroid cancer	0.00112	0.00406	CcSEcCtD
Loratadine—Dizziness—Sorafenib—thyroid cancer	0.00111	0.00404	CcSEcCtD
Loratadine—Vomiting—Sorafenib—thyroid cancer	0.00107	0.00388	CcSEcCtD
Loratadine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00107	0.00388	CcSEcCtD
Loratadine—Rash—Sorafenib—thyroid cancer	0.00106	0.00385	CcSEcCtD
Loratadine—Dermatitis—Sorafenib—thyroid cancer	0.00106	0.00385	CcSEcCtD
Loratadine—Headache—Sorafenib—thyroid cancer	0.00106	0.00383	CcSEcCtD
Loratadine—Gastritis—Doxorubicin—thyroid cancer	0.00104	0.00376	CcSEcCtD
Loratadine—Pollakiuria—Epirubicin—thyroid cancer	0.00101	0.00367	CcSEcCtD
Loratadine—Nausea—Sorafenib—thyroid cancer	0.001	0.00363	CcSEcCtD
Loratadine—Drowsiness—Epirubicin—thyroid cancer	0.000976	0.00354	CcSEcCtD
Loratadine—Pollakiuria—Doxorubicin—thyroid cancer	0.000936	0.00339	CcSEcCtD
Loratadine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000923	0.00335	CcSEcCtD
Loratadine—Epistaxis—Epirubicin—thyroid cancer	0.000921	0.00334	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—thyroid cancer	0.000903	0.00327	CcSEcCtD
Loratadine—Pharyngitis—Epirubicin—thyroid cancer	0.00087	0.00315	CcSEcCtD
Loratadine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000854	0.0031	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—thyroid cancer	0.000852	0.00309	CcSEcCtD
Loratadine—Tinnitus—Epirubicin—thyroid cancer	0.000817	0.00296	CcSEcCtD
Loratadine—Pharyngitis—Doxorubicin—thyroid cancer	0.000805	0.00292	CcSEcCtD
Loratadine—Immune system disorder—Epirubicin—thyroid cancer	0.000792	0.00287	CcSEcCtD
Loratadine—Arrhythmia—Epirubicin—thyroid cancer	0.000783	0.00284	CcSEcCtD
Loratadine—Alopecia—Epirubicin—thyroid cancer	0.000775	0.00281	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—thyroid cancer	0.000756	0.00274	CcSEcCtD
Loratadine—Tension—Epirubicin—thyroid cancer	0.000749	0.00271	CcSEcCtD
Loratadine—Dysgeusia—Epirubicin—thyroid cancer	0.000747	0.00271	CcSEcCtD
Loratadine—Nervousness—Epirubicin—thyroid cancer	0.000741	0.00269	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—thyroid cancer	0.000733	0.00265	CcSEcCtD
Loratadine—Arrhythmia—Doxorubicin—thyroid cancer	0.000725	0.00263	CcSEcCtD
Loratadine—Alopecia—Doxorubicin—thyroid cancer	0.000717	0.0026	CcSEcCtD
Loratadine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000708	0.00257	CcSEcCtD
Loratadine—Agitation—Epirubicin—thyroid cancer	0.000701	0.00254	CcSEcCtD
Loratadine—Tension—Doxorubicin—thyroid cancer	0.000693	0.00251	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—thyroid cancer	0.000691	0.00251	CcSEcCtD
Loratadine—Malaise—Epirubicin—thyroid cancer	0.000688	0.00249	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—thyroid cancer	0.000686	0.00248	CcSEcCtD
Loratadine—Syncope—Epirubicin—thyroid cancer	0.000684	0.00248	CcSEcCtD
Loratadine—Palpitations—Epirubicin—thyroid cancer	0.000674	0.00244	CcSEcCtD
Loratadine—Loss of consciousness—Epirubicin—thyroid cancer	0.000671	0.00243	CcSEcCtD
Loratadine—Cough—Epirubicin—thyroid cancer	0.000666	0.00241	CcSEcCtD
Loratadine—Hypertension—Epirubicin—thyroid cancer	0.000659	0.00239	CcSEcCtD
Loratadine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000655	0.00237	CcSEcCtD
Loratadine—Chest pain—Epirubicin—thyroid cancer	0.00065	0.00235	CcSEcCtD
Loratadine—Myalgia—Epirubicin—thyroid cancer	0.00065	0.00235	CcSEcCtD
Loratadine—Agitation—Doxorubicin—thyroid cancer	0.000649	0.00235	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000645	0.00234	CcSEcCtD
Loratadine—Discomfort—Epirubicin—thyroid cancer	0.000642	0.00233	CcSEcCtD
Loratadine—Malaise—Doxorubicin—thyroid cancer	0.000637	0.00231	CcSEcCtD
Loratadine—Dry mouth—Epirubicin—thyroid cancer	0.000635	0.0023	CcSEcCtD
Loratadine—Syncope—Doxorubicin—thyroid cancer	0.000633	0.00229	CcSEcCtD
Loratadine—Palpitations—Doxorubicin—thyroid cancer	0.000624	0.00226	CcSEcCtD
Loratadine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000623	0.00226	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000621	0.00225	CcSEcCtD
Loratadine—Cough—Doxorubicin—thyroid cancer	0.000616	0.00223	CcSEcCtD
Loratadine—Shock—Epirubicin—thyroid cancer	0.000613	0.00222	CcSEcCtD
Loratadine—Nervous system disorder—Epirubicin—thyroid cancer	0.000611	0.00221	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—thyroid cancer	0.00061	0.00221	CcSEcCtD
Loratadine—Tachycardia—Epirubicin—thyroid cancer	0.000608	0.0022	CcSEcCtD
Loratadine—Skin disorder—Epirubicin—thyroid cancer	0.000605	0.00219	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—thyroid cancer	0.000601	0.00218	CcSEcCtD
Loratadine—Chest pain—Doxorubicin—thyroid cancer	0.000601	0.00218	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000597	0.00216	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—thyroid cancer	0.000594	0.00215	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—thyroid cancer	0.000588	0.00213	CcSEcCtD
Loratadine—Hypotension—Epirubicin—thyroid cancer	0.000582	0.00211	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000576	0.00209	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000567	0.00206	CcSEcCtD
Loratadine—Shock—Doxorubicin—thyroid cancer	0.000567	0.00205	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000565	0.00205	CcSEcCtD
Loratadine—Insomnia—Epirubicin—thyroid cancer	0.000563	0.00204	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—thyroid cancer	0.000562	0.00204	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—thyroid cancer	0.00056	0.00203	CcSEcCtD
Loratadine—Paraesthesia—Epirubicin—thyroid cancer	0.000559	0.00203	CcSEcCtD
Loratadine—Somnolence—Epirubicin—thyroid cancer	0.000554	0.00201	CcSEcCtD
Loratadine—Dyspepsia—Epirubicin—thyroid cancer	0.000548	0.00199	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—thyroid cancer	0.000538	0.00195	CcSEcCtD
Loratadine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000538	0.00195	CcSEcCtD
Loratadine—Fatigue—Epirubicin—thyroid cancer	0.000537	0.00195	CcSEcCtD
Loratadine—Constipation—Epirubicin—thyroid cancer	0.000533	0.00193	CcSEcCtD
Loratadine—Pain—Epirubicin—thyroid cancer	0.000533	0.00193	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000525	0.0019	CcSEcCtD
Loratadine—Insomnia—Doxorubicin—thyroid cancer	0.000521	0.00189	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—thyroid cancer	0.000517	0.00187	CcSEcCtD
Loratadine—Feeling abnormal—Epirubicin—thyroid cancer	0.000513	0.00186	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—thyroid cancer	0.000512	0.00186	CcSEcCtD
Loratadine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000509	0.00185	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—thyroid cancer	0.000507	0.00184	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000497	0.0018	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—thyroid cancer	0.000497	0.0018	CcSEcCtD
Loratadine—Pain—Doxorubicin—thyroid cancer	0.000493	0.00179	CcSEcCtD
Loratadine—Constipation—Doxorubicin—thyroid cancer	0.000493	0.00179	CcSEcCtD
Loratadine—Abdominal pain—Epirubicin—thyroid cancer	0.000492	0.00178	CcSEcCtD
Loratadine—Body temperature increased—Epirubicin—thyroid cancer	0.000492	0.00178	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000475	0.00172	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000471	0.00171	CcSEcCtD
Loratadine—Body temperature increased—Doxorubicin—thyroid cancer	0.000456	0.00165	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—thyroid cancer	0.000456	0.00165	CcSEcCtD
Loratadine—Asthenia—Epirubicin—thyroid cancer	0.000447	0.00162	CcSEcCtD
Loratadine—Diarrhoea—Epirubicin—thyroid cancer	0.000426	0.00154	CcSEcCtD
Loratadine—Asthenia—Doxorubicin—thyroid cancer	0.000413	0.0015	CcSEcCtD
Loratadine—Dizziness—Epirubicin—thyroid cancer	0.000412	0.00149	CcSEcCtD
Loratadine—Vomiting—Epirubicin—thyroid cancer	0.000396	0.00143	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—thyroid cancer	0.000394	0.00143	CcSEcCtD
Loratadine—Rash—Epirubicin—thyroid cancer	0.000393	0.00142	CcSEcCtD
Loratadine—Dermatitis—Epirubicin—thyroid cancer	0.000392	0.00142	CcSEcCtD
Loratadine—Headache—Epirubicin—thyroid cancer	0.00039	0.00141	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—thyroid cancer	0.000381	0.00138	CcSEcCtD
Loratadine—Nausea—Epirubicin—thyroid cancer	0.00037	0.00134	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—thyroid cancer	0.000366	0.00133	CcSEcCtD
Loratadine—Rash—Doxorubicin—thyroid cancer	0.000363	0.00132	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—thyroid cancer	0.000363	0.00132	CcSEcCtD
Loratadine—Headache—Doxorubicin—thyroid cancer	0.000361	0.00131	CcSEcCtD
Loratadine—Nausea—Doxorubicin—thyroid cancer	0.000342	0.00124	CcSEcCtD
